- Home
- BNR vs ENGS Comparison
BNR vs ENGS Comparison
Compare BNR & ENGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- ENGS
- Stock Information
- Founded
- BNR 2014
- ENGS 1998
- Country
- BNR China
- ENGS United Kingdom
- Employees
- BNR N/A
- ENGS N/A
- Industry
- BNR Medical Specialities
- ENGS
- Sector
- BNR Health Care
- ENGS
- Exchange
- BNR Nasdaq
- ENGS NYSE
- Market Cap
- BNR 29.1M
- ENGS 23.8M
- IPO Year
- BNR 2020
- ENGS 2025
- Fundamental
- Price
- BNR $3.20
- ENGS $1.78
- Analyst Decision
- BNR
- ENGS
- Analyst Count
- BNR 0
- ENGS 0
- Target Price
- BNR N/A
- ENGS N/A
- AVG Volume (30 Days)
- BNR 38.8K
- ENGS 403.9K
- Earning Date
- BNR 06-06-2025
- ENGS 01-01-0001
- Dividend Yield
- BNR N/A
- ENGS N/A
- EPS Growth
- BNR N/A
- ENGS N/A
- EPS
- BNR N/A
- ENGS N/A
- Revenue
- BNR $72,112,038.00
- ENGS $11,089,930.00
- Revenue This Year
- BNR $136.32
- ENGS N/A
- Revenue Next Year
- BNR N/A
- ENGS N/A
- P/E Ratio
- BNR N/A
- ENGS N/A
- Revenue Growth
- BNR 0.53
- ENGS 6.58
- 52 Week Low
- BNR $2.18
- ENGS $1.36
- 52 Week High
- BNR $7.90
- ENGS $10.24
- Technical
- Relative Strength Index (RSI)
- BNR 48.34
- ENGS N/A
- Support Level
- BNR $3.06
- ENGS N/A
- Resistance Level
- BNR $3.50
- ENGS N/A
- Average True Range (ATR)
- BNR 0.36
- ENGS 0.00
- MACD
- BNR -0.04
- ENGS 0.00
- Stochastic Oscillator
- BNR 20.16
- ENGS 0.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About ENGS ENERGYS GROUP LTD
Energys Group Ltd provides end-to-end customized solutions and services involving the retrofitting of existing infrastructure to reduce their CO2 emissions. The Company's customers include large national account end-users, including universities, schools, hospitals and electrical distributors in the United Kingdom.